Skip to content

Probiotics to Prevent Infections in Premature Infants in the Intensive Care Unit

Investigating The effect of Probiotics on the prevention of hospital-acquired infections in very low birth weight premature infants admitted to the intensive care unit

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171218037936N5
Enrollment
100
Registered
2025-12-19
Start date
2025-12-26
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity and very low birth weight in neonates (preterm infants with birth weight less than 1500 grams).. Preterm [premature] newborn [other]

Interventions

Intervention 1: Intervention group: Participants in this group will receive 5 drops per day of the probiotic Lactobacillus reuteri (commercially available as Prokid, manufactured by Gostaresh Milad Ph

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 30 Days

Inclusion criteria

Inclusion criteria: Very low birth weight (VLBW) premature infants (birth weight < 1500 grams). Admission to the Neonatal Intensive Care Unit (NICU) of Shahid Motahari Hospital, Urmia. Admission during the study period in the year 1404 (2025-2026). Parental or legal guardian informed consent obtained for participation.

Exclusion criteria

Exclusion criteria: Premature infants with a gestational age of less than 28 weeks at birth. Deterioration of the infant's clinical condition after enrollment in the study. Parental withdrawal of consent for continued participation in the study.

Design outcomes

Primary

MeasureTime frame
The incidence of necrotizing enterocolitis (NEC), defined as inflammation and bacterial invasion of the intestinal wall leading to cellular damage and necrosis. Timepoint: The outcome will be assessed daily from the start of the intervention (probiotic/placebo administration) until discharge from the neonatal intensive care unit (NICU), death, or reaching 40 weeks of postmenstrual age. Method of measurement: Diagnosis will be based on the modified Bell's staging criteria, incorporating clinical signs (abdominal distension, gastric residuals, bloody stools), radiographic findings (pneumatosis intestinalis, portal venous gas, pneumoperitoneum on abdominal X-ray), and/or pathological confirmation during surgery or autopsy.

Secondary

MeasureTime frame
The incidence of Ventilator-Associated Pneumonia (VAP), defined as a pneumonia (lung infection) that develops in a patient who has been on mechanical ventilation for more than 48 hours. Timepoint: The outcome will be assessed daily from the start of the intervention until successful extubation, discharge from the neonatal intensive care unit (NICU), death, or reaching 40 weeks of postmenstrual age. Method of measurement: Diagnosis will be made based on the Centers for Disease Control and Prevention criteria for Ventilator-Associated Pneumonia, which require a combination of new or worsening infiltrates on chest radiograph plus clinical signs (e.g., fever, increased secretions, worsening gas exchange) and microbiological findings (positive culture from endotracheal aspirate or bronchoalveolar lavage).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKamran Dehghan

Oroumia University of Medical Sciences

dehghan.k@umsu.ac.ir+98 44 3365 4154

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026